期刊文献+

川龙抑癌汤联合TURP术治疗晚期激素非依赖性前列腺癌30例临床观察 被引量:6

Efficacy of Chuanlongyiai Decoction(川龙抑癌汤) combined with TUPR on Advanced Hormone-independent Prostate Cancer: A Clinical Observation of 30 Cases
下载PDF
导出
摘要 目的:观察川龙抑癌汤联合TURP术治疗晚期激素非依赖性前列腺癌的临床疗效。方法:将符合纳入标准的经病理确诊为激素非依赖性前列腺癌患者共60例随机分为两组,每组各30例,对照组行TURP术;治疗组在此基础上予以川龙抑癌汤治疗。治疗后,观察两组患者临床症状的变化、PSA水平、最大尿流率、残余尿量、生活质量等指标的改变。结果:治疗后,治疗组临床总有效率为76.7%,明显高于对照组的56.7%;治疗组生存质量卡氏评分的有效率为90.0%,高于对照组的73.3%,两组比较,差异均有统计学意义(P<0.05);两组治疗后PAS水平、残余尿量等指标均较前显著降低(P<0.05),且治疗组较对照组下降更明显(P<0.05);两组治疗后最大尿流率均增加,与治疗前比较差异均具有统计学意义(P<0.05),且治疗组与对照组比较增加更明显(P<0.05)。结论:川龙抑癌汤联合TURP术治疗晚期激素非依赖前列腺癌的临床疗效佳,可明显改善患者的临床症状,提高生存质量,降低PAS水平。 [Abstract] Objective: To evaluate clinical efficacy of Chuanlongyiai Decoction combined with TUPR on advanced hormone- independent prostate cancer. Methods: The 60 cases which met the inclusion criteria were randomly divided into two groups, 30 cases in each. Patients were given TUPR treatment, and Chuanlongyiai Decoction (川龙抑癌汤) combined with TUPR in treat- ment group. Changes of clinical symptoms change, PSA level, maximum flow rate, residual urine volume, quality of life indica- tors were observed after treatment in two groups. Results: After treatment, the total effective rate of treatment group was 76.7%, which was significantly higher than the control group of 56.7%. The effective rate of Karnofsky score in the treatment group was 90.0%, which was higher than the control group of 73.3%. The differences were statistically significant (P〈0.05); PAS level and residual urine volume were significantly lower after treatment (P〈0.05) in two groups, and the treatment group decreased more significantly than the control group (P〈0.05). The maximum urinary flow rate increased in two groups, and the difference was sta- tistically significant (P〈0.05). The treatment group increased more significantly than the control group(P〈0.05). Conclusion: Chuanlongyiai Decoction combined with TUPR can provide good efficacy for advanced hormone-independent prostate cancer, improve the clinical symptoms, improve quality of life, and reduce PAS level.
作者 康川疆
机构地区 遂宁市中心医院
出处 《中医药导报》 2015年第15期51-53,共3页 Guiding Journal of Traditional Chinese Medicine and Pharmacy
关键词 川龙抑癌汤 TUPR 激素非依赖性 前列腺癌 中西医结合疗法 Chuanlongyiai Decoction TUPR Hormone-independent prostate cancer Integrated traditional Chinese andWestern medicine therapy
  • 相关文献

参考文献5

  • 1Engel-Nitz N M, Alemayehu B,Parry D,et al. Differ- ences in treatment patterns among patients with castra- tion- resist-ant prostate cancer treated by oncologists versus urologists in a US managed carepopulation [J]. Cancer Manag Res, 2011,7(3) : 233-245.
  • 2Emil A.Tanagho, Jack W. McAninch. Smiths Gener- alUrologyl6e[M]. McGraw-HillCompanies, Inc. 2004.
  • 3JEMALA, BRAY F, CENTER M M, et al.Global can- cer statistics[J].CA Cancer J Clin,2011,61:69-90.
  • 4胡玉兰,徐海荣,刘佳宾.放射治疗在前列腺癌治疗中的应用进展[A]//中国遗传学会.中国遗传学会“第十一届全国激光生物学学术会议”暨《激光生物学报》创刊廿周年庆祝会、第十届粤港生物物理研讨会暨2012年广东生物物理学术年会会议资料[c].中国遗传学会,2012:4.
  • 5高文华,徐是.经尿道前列腺电切联合内分泌治疗晚期前列腺癌[J].江西医药,2014,49(8):692-694. 被引量:4

二级参考文献8

共引文献3

同被引文献58

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部